MarketCap
Facebook
X
Telegram
Merus N.V. Long Term Debt Current | MRUS
Annual Long Term Debt Current Merus N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.7 M | 1.67 M | 1.68 M | 1.49 M | 1.43 M | 1.38 M | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.7 M | 1.38 M | 1.56 M |
Long Term Debt Current of other stocks in the Biotechnology industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abeona Therapeutics
ABEO
|
864 K | $ 2.35 | -4.28 % | $ 124 M |  USA |
 |
ACADIA Pharmaceuticals
ACAD
|
11.6 M | $ 18.38 | 0.55 % | $ 3.09 B | USA |
 |
PainReform Ltd.
PRFX
|
21 K | $ 0.74 | -6.69 % | $ 480 K |  Israel |
 |
Atossa Therapeutics
ATOS
|
18.1 K | $ 2.04 | -4.67 % | $ 17.6 M | USA |
 |
PDS Biotechnology Corporation
PDSB
|
231 K | $ 1.01 | -1.46 % | $ 46.8 M | USA |
 |
ADC Therapeutics SA
ADCT
|
538 K | $ 1.6 | 5.3 % | $ 203 M |  Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
1.07 M | $ 34.22 | 2.0 % | $ 1.97 B | USA |
 |
Ardelyx
ARDX
|
1.48 M | $ 3.14 | 4.15 % | $ 757 M | USA |
 |
Akebia Therapeutics
AKBA
|
3.55 M | $ 0.57 | 5.2 % | $ 147 M | USA |
 |
Alector
ALEC
|
9.06 M | $ 2.62 | 3.56 % | $ 270 M | USA |
 |
ALX Oncology Holdings
ALXO
|
901 K | $ 1.12 | 0.9 % | $ 60.1 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
6.76 M | $ 21.71 | 1.52 % | $ 6.8 B | USA |
 |
Phathom Pharmaceuticals
PHAT
|
648 K | $ 6.28 | 15.34 % | $ 458 M | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
547 K | $ 3.88 | 1.44 % | $ 743 M |  Canada |
 |
Agenus
AGEN
|
1.03 M | $ 7.24 | 3.06 % | $ 215 M | USA |
 |
AbCellera Biologics
ABCL
|
5.82 M | $ 12.15 | -2.53 % | $ 3.63 B | Canada |
 |
Artelo Biosciences
ARTL
|
40 K | $ 2.2 | 2.7 % | $ 416 K | USA |
|
Immatics N.V.
IMTX
|
2.76 M | $ 6.69 | 4.13 % | $ 819 M |  Germany |
 |
Aptevo Therapeutics
APVO
|
866 K | $ 0.77 | -28.31 % | $ 243 K | USA |
 |
Aligos Therapeutics
ALGS
|
3.58 M | $ 2.17 | -15.56 % | $ 21.5 M | USA |
 |
Aclaris Therapeutics
ACRS
|
551 K | $ 4.35 | 4.82 % | $ 533 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
8.92 M | $ 29.93 | 1.94 % | $ 4.54 B | USA |
 |
Cellectar Biosciences
CLRB
|
100 K | $ 1.21 | -0.82 % | $ 3.16 M | USA |
|
Larimar Therapeutics
LRMR
|
1.1 M | $ 2.74 | 1.67 % | $ 228 M | USA |
 |
Replimune Group
REPL
|
1.16 M | $ 21.77 | -6.49 % | $ 2.02 B | USA |
 |
Pharming Group N.V.
PHAR
|
1.6 M | $ 13.4 | 2.92 % | $ 9.23 B |  Niderland |
 |
Capricor Therapeutics
CAPR
|
202 K | $ 11.21 | 26.38 % | $ 521 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
7.93 M | $ 28.59 | -1.62 % | $ 1.34 B | USA |
 |
Aquestive Therapeutics
AQST
|
631 K | $ 3.59 | 1.85 % | $ 384 M | USA |
 |
Jaguar Health
JAGX
|
192 K | $ 0.48 | 10.08 % | $ 1.12 M | USA |
 |
Arvinas
ARVN
|
1.7 M | $ 6.92 | -0.36 % | $ 491 M | USA |
 |
Cerus Corporation
CERS
|
2.9 M | $ 2.12 | 8.46 % | $ 404 M | USA |
 |
Beam Therapeutics
BEAM
|
14.4 M | $ 25.99 | 3.34 % | $ 2.57 B | USA |
 |
Pulmatrix
PULM
|
429 K | $ 1.31 | -2.96 % | $ 4.78 B | USA |
 |
Fortress Biotech
FBIO
|
2.13 M | $ 2.02 | 5.65 % | $ 56.4 M | USA |
 |
Inhibrx
INBX
|
2.06 M | $ 90.76 | 0.17 % | $ 4.28 B | USA |
 |
Entera Bio Ltd.
ENTX
|
230 K | $ 3.21 | -0.9 % | $ 148 M | Israel |
 |
Legend Biotech Corporation
LEGN
|
7.4 M | $ 19.66 | -3.7 % | $ 7.25 B | USA |
 |
CytomX Therapeutics
CTMX
|
4.24 M | $ 2.15 | 8.59 % | $ 297 M | USA |
 |
Krystal Biotech
KRYS
|
1.77 M | $ 310.6 | 1.34 % | $ 8.99 B | USA |
 |
Kura Oncology
KURA
|
1.28 M | $ 7.74 | 2.18 % | $ 679 M | USA |
 |
Inhibikase Therapeutics
IKT
|
150 K | $ 1.64 | 5.48 % | $ 161 M | USA |
 |
Heron Therapeutics
HRTX
|
3.04 M | $ 0.36 | -3.39 % | $ 60 M | USA |
 |
Inovio Pharmaceuticals
INO
|
2.82 M | $ 1.44 | -1.03 % | $ 67.5 M | USA |